Orforglipron is the first new molecular entity cleared under the FDA's Commissioner's National Priority Voucher (CNPV) pilot ...

April 1 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli Lilly. Analysts forecast the industry will generate ...

April 1 () - Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

The State of Texas will launch its own program to research a psychoactive drug called ibogaine after it was unable to find a ...

When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.

EMA states that reduction in animal testing will be gradual. The first qualification opinion for a NAM used in toxicity ...

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...